Kolon TissueGene
Kolon TissueGene is a biotechnology company developing cell and gene therapies for treating osteoarthritis.
2
Funding Rounds
$59.7m
Money raised
Overview
Kolon TissueGene is a biotechnology company developing cell and gene therapies for treating osteoarthritis.
- Websites:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Kolon TissueGene has raised a total of $59.73m in funding over 2 rounds.
Key Insights:
- Kolon TissueGene Funding Round, August 2022: $29.64m
- Kolon TissueGene Funding Round, December 2021: $30.09m
Kolon TissueGene Funding Round, August 2022
$29.64m
Kolon TissueGene Funding Round, December 2021
$30.09m
Industries
Kolon TissueGene is active in the following industries: